This inventor holds 4 USPTO granted patents and 8 published patent applications. Top assignees: Beam Therapeutics Inc., Guide Therapeutics, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Milloni Balwantkumar Chhabra: Innovator in Nanomaterials
Introduction
Milloni Balwantkumar Chhabra is a notable inventor based in Dunwoody, GA (US). He has made significant contributions to the field of nanomaterials, particularly in the development of lipid nanoparticle compositions for the delivery of nucleic acids. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing technology.
Latest Patents
Chhabra holds 4 patents that highlight his research in nanomaterials. His latest patents include compositions that utilize lipid nanoparticles for the targeted delivery of therapeutic cargo. These lipid nanoparticles contain an ionizable lipid of a specific formula, allowing for effective delivery without the need for a targeting ligand. Additionally, he has developed nanomaterials that incorporate biodegradable features, which further enhance their utility in various applications.
Career Highlights
Throughout his career, Milloni Chhabra has worked with prominent companies in the biotechnology sector. He has been associated with Beam Therapeutics Inc. and Guide Therapeutics, Inc., where he has contributed to groundbreaking research and development efforts. His work in these organizations has solidified his reputation as an innovator in the field.
Collaborations
Chhabra has collaborated with esteemed colleagues, including Gregory Lawrence Hamilton and Mina Fawzy Shehata. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in nanotechnology.
Conclusion
Milloni Balwantkumar Chhabra is a distinguished inventor whose work in nanomaterials has the potential to revolutionize therapeutic delivery systems. His patents and collaborations reflect his commitment to innovation and excellence in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile